| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 12.875 | 65.162 | 82.526 | 80.185 | 90.949 | 101.794 | 139.969 | 151.292 |
| Total Income - EUR | - | - | 12.875 | 65.189 | 82.532 | 80.187 | 90.952 | 101.799 | 139.979 | 151.307 |
| Total Expenses - EUR | - | - | 6.226 | 23.338 | 22.636 | 31.486 | 29.143 | 35.800 | 36.768 | 59.769 |
| Gross Profit/Loss - EUR | - | - | 6.649 | 41.851 | 59.896 | 48.702 | 61.809 | 65.999 | 103.211 | 91.539 |
| Net Profit/Loss - EUR | - | - | 6.520 | 41.201 | 59.067 | 47.933 | 61.009 | 65.002 | 101.839 | 87.090 |
| Employees | - | - | 3 | 3 | 2 | 3 | 3 | 3 | 3 | 3 |
Check the financial reports for the company - Dermaver Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 0 | 78 | 994 | 1.224 | 986 | 519 | 38.250 | 37.419 |
| Current Assets | - | - | 10.497 | 50.048 | 65.728 | 68.980 | 78.038 | 87.156 | 95.257 | 54.428 |
| Inventories | - | - | 0 | 0 | 0 | 0 | 412 | 419 | 1.123 | 1.026 |
| Receivables | - | - | 4.278 | 5.816 | 7.511 | 8.126 | 15.413 | 22.293 | 33.474 | 13.304 |
| Cash | - | - | 6.219 | 44.233 | 58.218 | 60.853 | 62.212 | 64.445 | 60.660 | 40.097 |
| Shareholders Funds | - | - | 6.564 | 41.244 | 59.109 | 47.974 | 61.049 | 65.042 | 101.880 | 87.130 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 3.932 | 8.882 | 7.613 | 22.229 | 18.061 | 22.676 | 31.639 | 4.716 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Dermaver Med S.r.l.